Company Profile

Accunovo Biotechnologies Inc
Profile last edited on: 1/19/24      CAGE: 8FAR0      UEI: DAF9XL6P2BG5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

211 Lake Manor Road
Chapel Hill, NC 27516
   (626) 500-9435
Location: Single
Congr. District: 04
County: Orange

Public Profile

Accunovo is bio-science firm developing novel targeted PET imaging probes structured around the combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. Potential end market(s) are suggested to nclude: Diagnostics; herapeutics - Small Molecule; Cancers and other Neoplasms. Products under development include prostate cancer theronostic agents

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $376,447
Project Title: Theranostic NTSR1-targeting Agents for Complementary Management of PSMA-negative Prostate Cancer

Key People / Management

  Lisa Lee -- CEO

  Xiaomei Li

Company News

There are no news available.